×
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
OTCMKTS:RDSMY

Koninklijke DSM Stock Forecast, Price & News

$36.03
-0.78 (-2.12%)
(As of 06/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$35.76
$36.40
50-Day Range
$34.47
$42.44
52-Week Range
$34.13
$56.92
Volume
60,243 shs
Average Volume
67,012 shs
Market Capitalization
$25.19 billion
P/E Ratio
N/A
Dividend Yield
1.98%
Price Target
$178.00
30 days | 90 days | 365 days | Advanced Chart

Receive RDSMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Koninklijke DSM and its competitors with MarketBeat's FREE daily newsletter.

RDSMY Stock Forecast (MarketRank)

Overall MarketRank

2.09 out of 5 stars

Analyst Opinion: 3.4Community Rank: 4.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
Koninklijke DSM logo

About Koninklijke DSM (OTCMKTS:RDSMY)

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

RDSMY Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Current Symbol
OTCMKTS:RDSMY
Previous Symbol
NASDAQ:RDSMY
Employees
21,358
Year Founded
N/A

Company Calendar

Last Earnings
11/03/2020
Ex-Dividend for 6/10 Dividend
5/13/2022
Dividend Payable
6/10/2022
Today
6/29/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$178.00
High Stock Price Forecast
$188.00
Low Stock Price Forecast
$155.00
Forecasted Upside/Downside
+394.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.8
Research Coverage
10 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.89 billion
Cash Flow
$2.26 per share
Book Value
$11.78 per share

Miscellaneous

Free Float
N/A
Market Cap
$25.19 billion
Optionable
Not Optionable
Beta
0.89














Koninklijke DSM Frequently Asked Questions

Should I buy or sell Koninklijke DSM stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Koninklijke DSM in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Koninklijke DSM stock.
View analyst ratings for Koninklijke DSM
or view top-rated stocks.

What is Koninklijke DSM's stock price forecast for 2022?

10 brokers have issued 1-year target prices for Koninklijke DSM's shares. Their RDSMY stock forecasts range from $155.00 to $188.00. On average, they anticipate Koninklijke DSM's stock price to reach $178.00 in the next year. This suggests a possible upside of 394.0% from the stock's current price.
View analysts' price targets for Koninklijke DSM
or view top-rated stocks among Wall Street analysts.

How has Koninklijke DSM's stock performed in 2022?

Koninklijke DSM's stock was trading at $56.61 on January 1st, 2022. Since then, RDSMY stock has decreased by 36.4% and is now trading at $36.03.
View the best growth stocks for 2022 here
.

Are investors shorting Koninklijke DSM?

Koninklijke DSM saw a increase in short interest in June. As of June 15th, there was short interest totaling 35,600 shares, an increase of 256.0% from the May 31st total of 10,000 shares. Based on an average daily trading volume, of 129,400 shares, the days-to-cover ratio is presently 0.3 days.
View Koninklijke DSM's Short Interest
.

How were Koninklijke DSM's earnings last quarter?

Koninklijke DSM (OTCMKTS:RDSMY) announced its earnings results on Tuesday, November, 3rd. The basic materials company reported $0.30 earnings per share for the quarter, missing analysts' consensus estimates of $0.31 by $0.01. The basic materials company earned $2.29 billion during the quarter.
View Koninklijke DSM's earnings history
.

How often does Koninklijke DSM pay dividends? What is the dividend yield for Koninklijke DSM?

Koninklijke DSM announced a dividend on Friday, May 13th. Shareholders of record on Monday, May 16th will be given a dividend of $0.3593 per share on Friday, June 10th. This represents a dividend yield of 1.5%. The ex-dividend date of this dividend is Friday, May 13th.
View Koninklijke DSM's dividend history
.

Is Koninklijke DSM a good dividend stock?

Koninklijke DSM(OTCMKTS:RDSMY) pays an annual dividend of $0.73 per share and currently has a dividend yield of 1.98%.
View Koninklijke DSM's dividend history.

Who are Koninklijke DSM's key executives?

Koninklijke DSM's management team includes the following people:
  • Mr. Dimitri de Vreeze, Co-CEO, COO & Member of the Managing Board (Age 55, Pay $2.13M)
  • Ms. Geraldine Matchett, Co-CEO, CFO, Member of the Managing Board & Acting EVP of People & Organization (Age 50, Pay $2.07M)
  • Mr. Dave Huizing, VP of Investor Relations
  • Ms. Lieke de Jong-Tops, Sr. Communications Mang.
  • Mr. Rob J. Atsma, Head of Energie Beheer Nederland (Age 76)
  • Mr. Paul Gilgen, Head of Manufacturing & Purchasing of DSM Nutritional Products (Age 77)
  • Mr. Manfred Eggersdorfer, Sr. VP of Nutrition Science & Advocacy (Age 71)
  • Mr. Bruno Müller, Head of Strategy & VITAL Project - Nutritional Products (Age 66)
  • Mr. Jan Wolters, Head of Fine Chemicals (Age 79)
  • Mr. Luca Rosetto, Sr. VP of Operations - Nutritional Products (Age 59)

What is Koninklijke DSM's stock symbol?

Koninklijke DSM trades on the OTCMKTS under the ticker symbol "RDSMY."

How do I buy shares of Koninklijke DSM?

Shares of RDSMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Koninklijke DSM's stock price today?

One share of RDSMY stock can currently be purchased for approximately $36.03.

How much money does Koninklijke DSM make?

Koninklijke DSM (OTCMKTS:RDSMY) has a market capitalization of $25.19 billion and generates $10.89 billion in revenue each year.

How many employees does Koninklijke DSM have?

Koninklijke DSM employs 21,358 workers across the globe.

How can I contact Koninklijke DSM?

Koninklijke DSM's mailing address is Het Overloon 1, Heerlrn P7, 6411 TE. The official website for Koninklijke DSM is www.dsm.com. The basic materials company can be reached via phone at (145) 578-8111 or via fax at 31-45-571-9753.

This page (OTCMKTS:RDSMY) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.